RB1 and neoplasm: The results depicted in Figure 11 identify miR-29a and miR-145 as potential inhibitors of the CDK2/Cyclin E complex and E2F through FFLs and Type III regulatory loops and suggest that these miRNAs work in concert with p27 and Rb tumor suppressors, preventing passage from the G1 to the S phase.